Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening (Q24813875)

5 July 2017

1 reference

title

Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening (English)

1 reference

randomized controlled trial

5 July 2017

1 reference

inferred from title

breast cancer screening

1 reference

1 reference

Sue Moss

1

1 reference

PubMed ID

16168145

5 July 2017

language of work or name

English

0 references

publication date

25 August 2005

1 reference

5 July 2017

Breast Cancer Research

1 reference

5 July 2017

7

1 reference

5 July 2017

5

1 reference

5 July 2017

230-234

1 reference

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures

5 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

Evidence on screening for breast cancer from a randomized trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

The Gothenburg Breast Screening Trial.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242166

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.

30 May 2018

1 reference

The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.

21 January 2018

1 reference

Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

21 January 2018

1 reference

The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.

21 January 2018

1 reference

A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.

21 January 2018

1 reference

Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16168145

12 December 2020

inferred from PubMed ID database lookup

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16168145

12 December 2020

inferred from PubMed ID database lookup

Ten- to fourteen-year effect of screening on breast cancer mortality

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16168145

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/BCR1314

1 reference

PubMed ID

16168145

Dimensions Publication ID

5 July 2017

0 references

1 reference

5 July 2017

1 reference

PubMed ID

16168145